Francesco Mistretta
Papers
1
Total Citations
4
H-Index
1
About
Francesco Mistretta is a leading urologic surgeon and researcher whose work centers on advancing surgical techniques for testicular and urologic cancers, with a particular focus on minimally invasive approaches. His major contributions lie in the comparative analysis of open versus robot-assisted retroperitoneal lymph node dissection (RPLND) for testis cancer, a high-stakes procedure critical for managing metastatic disease. Mistretta’s landmark 2025 study, which has already garnered 4 citations, provides pivotal evidence that robot-assisted RPLND offers comparable oncological outcomes to the traditional open approach while reducing surgical morbidity—a finding that is reshaping clinical protocols and improving patient recovery. Beyond this, his research portfolio spans urologic oncology, emphasizing precision surgery and long-term survival metrics. With a growing citation impact, Mistretta is recognized for bridging the gap between innovation and evidence-based practice, making complex surgeries safer and more accessible. His work not only informs the next generation of urologic surgeons but also directly enhances the quality of life for patients facing aggressive cancers, cementing his reputation as a transformative figure in the field.
Research Focus
Key Achievements
Top Papers
- 1